Format
Sort by
Items per page

Send to

Choose Destination

Best matches for von Büdingen H[au]:

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial. Green AJ et al. Lancet. (2017)

Long-term evolution of multiple sclerosis disability in the treatment era. University of California, San Francisco MS-EPIC Team:. et al. Ann Neurol. (2016)

B lymphocytes in neuromyelitis optica. Bennett JL et al. Neurol Neuroimmunol Neuroinflamm. (2015)

Search results

Items: 49

1.

IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis.

Setiadi AF, Abbas AR, Jeet S, Wong K, Bischof A, Peng I, Lee J, Bremer M, Eggers EL, DeVoss J, Staton T, Herman A, von Büdingen HC, Townsend MJ.

J Neuroimmunol. 2019 Jul 15;332:147-154. doi: 10.1016/j.jneuroim.2019.04.011. Epub 2019 Apr 21.

2.

Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.

Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC.

JCI Insight. 2019 Mar 21;4(6). pii: 126599. doi: 10.1172/jci.insight.126599. eCollection 2019 Mar 21.

3.

Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.

Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC.

JCI Insight. 2017 Nov 16;2(22). pii: 92724. doi: 10.1172/jci.insight.92724. eCollection 2017 Nov 16.

4.

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.

Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR.

Lancet. 2017 Dec 2;390(10111):2481-2489. doi: 10.1016/S0140-6736(17)32346-2. Epub 2017 Oct 10.

5.

A Haystack Heuristic for Autoimmune Disease Biomarker Discovery Using Next-Gen Immune Repertoire Sequencing Data.

Apeltsin L, Wang S, von Büdingen HC, Sirota M.

Sci Rep. 2017 Jul 13;7(1):5338. doi: 10.1038/s41598-017-04439-5.

6.

Onset of secondary progressive MS after long-term rituximab therapy - a case report.

von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL.

Ann Clin Transl Neurol. 2016 Dec 20;4(1):46-52. doi: 10.1002/acn3.377. eCollection 2017 Jan.

7.

B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue.

Lehmann-Horn K, Wang SZ, Sagan SA, Zamvil SS, von Büdingen HC.

JCI Insight. 2016 Dec 8;1(20):e87234. doi: 10.1172/jci.insight.87234.

8.

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery.

Mei F, Lehmann-Horn K, Shen YA, Rankin KA, Stebbins KJ, Lorrain DS, Pekarek K, A Sagan S, Xiao L, Teuscher C, von Büdingen HC, Wess J, Lawrence JJ, Green AJ, Fancy SP, Zamvil SS, Chan JR.

Elife. 2016 Sep 27;5. pii: e18246. doi: 10.7554/eLife.18246.

9.

Long-term evolution of multiple sclerosis disability in the treatment era.

University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von Büdingen HC, Zamvil SS, Agrawal A, Caillier S, Ciocca C, Gomez R, Kanner R, Lincoln R, Lizee A, Qualley P, Santaniello A, Suleiman L, Bucci M, Panara V, Papinutto N, Stern WA, Zhu AH, Cutter GR, Baranzini S, Henry RG, Hauser SL.

Ann Neurol. 2016 Oct;80(4):499-510. doi: 10.1002/ana.24747. Epub 2016 Aug 13.

10.

The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.

von Büdingen HC, Mei F, Greenfield A, Jahn S, Shen YA, Reid HH, McKemy DD, Chan JR.

J Cell Biol. 2015 Sep 14;210(6):891-8.

11.

The active intrathecal B-cell response in LGI1-antibody encephalitis.

Irani SR, Lehmann-Horn K, Geschwind M, Wang S, Vincent A, von Büdingen HC.

Lancet. 2015 Feb 26;385 Suppl 1:S46. doi: 10.1016/S0140-6736(15)60361-0. Erratum in: Lancet. 2015 Oct 3;386(10001):1340.

PMID:
26312868
12.

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.

Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA, Hauser SL, Henry RG.

JAMA Neurol. 2015 Aug;72(8):897-904. doi: 10.1001/jamaneurol.2015.0993.

13.

B lymphocytes in neuromyelitis optica.

Bennett JL, O'Connor KC, Bar-Or A, Zamvil SS, Hemmer B, Tedder TF, von Büdingen HC, Stuve O, Yeaman MR, Smith TJ, Stadelmann C.

Neurol Neuroimmunol Neuroinflamm. 2015 May 7;2(3):e104. doi: 10.1212/NXI.0000000000000104. eCollection 2015 Jun. Review.

14.

Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targets.

von Büdingen HC, Palanichamy A, Lehmann-Horn K, Michel BA, Zamvil SS.

Eur Neurol. 2015;73(3-4):238-46. doi: 10.1159/000377675. Epub 2015 Mar 25. Review.

15.

Precision medicine in chronic disease management: The multiple sclerosis BioScreen.

Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-Hartman E, Nelson S, Baranzini SE, Hauser SL.

Ann Neurol. 2014 Nov;76(5):633-42. doi: 10.1002/ana.24282. Epub 2014 Oct 14. Review.

16.

Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.

Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, Sundar PD, Telman D, Zhao LZ, Derstine M, Abounasr A, Hauser SL, von Büdingen HC.

Sci Transl Med. 2014 Aug 6;6(248):248ra106. doi: 10.1126/scitranslmed.3008930.

17.

Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG.

Ann Neurol. 2014 Oct;76(4):568-80. doi: 10.1002/ana.24241. Epub 2014 Aug 21.

18.

CD19 as a molecular target in CNS autoimmunity.

Stüve O, Warnke C, Deason K, Stangel M, Kieseier BC, Hartung HP, von Büdingen HC, Centonze D, Forsthuber TG, Knappertz V.

Acta Neuropathol. 2014 Aug;128(2):177-90. doi: 10.1007/s00401-014-1313-z. Epub 2014 Jul 4. Review.

19.

Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.

Palanichamy A, Jahn S, Nickles D, Derstine M, Abounasr A, Hauser SL, Baranzini SE, Leppert D, von Büdingen HC.

J Immunol. 2014 Jul 15;193(2):580-586. doi: 10.4049/jimmunol.1400118. Epub 2014 Jun 13.

20.

In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses.

Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, von Büdingen HC.

Ann Neurol. 2014 Feb;75(2):266-76. doi: 10.1002/ana.24088. Epub 2014 Feb 20.

21.

B cell exchange across the blood-brain barrier in multiple sclerosis.

von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL.

J Clin Invest. 2012 Dec;122(12):4533-43. doi: 10.1172/JCI63842. Epub 2012 Nov 19.

22.

Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation.

Glanville J, Kuo TC, von Büdingen HC, Guey L, Berka J, Sundar PD, Huerta G, Mehta GR, Oksenberg JR, Hauser SL, Cox DR, Rajpal A, Pons J.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20066-71. doi: 10.1073/pnas.1107498108. Epub 2011 Nov 28.

23.

Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.

Menge T, Lalive PH, von Büdingen HC, Genain CP.

J Neuroinflammation. 2011 Nov 17;8:161. doi: 10.1186/1742-2094-8-161.

24.

B cells in multiple sclerosis: connecting the dots.

von Büdingen HC, Bar-Or A, Zamvil SS.

Curr Opin Immunol. 2011 Dec;23(6):713-20. doi: 10.1016/j.coi.2011.09.003. Epub 2011 Oct 7. Review.

25.

Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands".

von Büdingen HC, Gulati M, Kuenzle S, Fischer K, Rupprecht TA, Goebels N.

J Neuroimmunol. 2010 Jan 25;218(1-2):134-9. doi: 10.1016/j.jneuroim.2009.10.005. Epub 2009 Nov 8.

PMID:
19900722
26.

Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.

Harrer MD, von Büdingen HC, Stoppini L, Alliod C, Pouly S, Fischer K, Goebels N.

Exp Neurol. 2009 Apr;216(2):431-8.

PMID:
19320002
27.

Intravenous thrombolysis in stroke patients with hyperdense middle cerebral artery sign.

Georgiadis D, Wirz F, von Büdingen HC, Valko P, Hund-Georgiadis M, Nedeltchev K, Rousson V, Baumgartner RW.

Eur J Neurol. 2009 Feb;16(2):162-7. doi: 10.1111/j.1468-1331.2008.02369.x. Epub 2008 Dec 9.

PMID:
19138342
28.

Disease-modifying agents for multiple sclerosis: recent advances and future prospects.

Menge T, Weber MS, Hemmer B, Kieseier BC, von Büdingen HC, Warnke C, Zamvil SS, Boster A, Khan O, Hartung HP, Stüve O.

Drugs. 2008;68(17):2445-68. doi: 10.2165/0003495-200868170-00004. Review.

PMID:
19016573
29.

Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.

von Büdingen HC, Harrer MD, Kuenzle S, Meier M, Goebels N.

Eur J Immunol. 2008 Jul;38(7):2014-23. doi: 10.1002/eji.200737784. Erratum in: Eur J Immunol. 2008 Jul;38(7):2046-7.

30.

Rotational vertebral artery syndrome: 3D kinematics of nystagmus suggest bilateral labyrinthine dysfunction.

Marti S, Hegemann S, von Büdingen HC, Baumgartner RW, Straumann D.

J Neurol. 2008 May;255(5):663-7. doi: 10.1007/s00415-008-0773-2. Epub 2008 Feb 18.

31.

Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.

Menge T, von Büdingen HC, Lalive PH, Genain CP.

Eur J Immunol. 2007 Nov;37(11):3229-39.

32.

Serum cholesterol levels do not influence outcome or recovery in acute ischemic stroke.

von Büdingen HC, Baumgartner RW, Baumann CR, Rousson V, Siegel AM, Georgiadis D.

Neurol Res. 2008 Feb;30(1):82-4.

33.

Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.

Baumann CR, Baumgartner RW, von Büdingen HC, Rousson V, Siegel AM, Georgiadis D.

Cerebrovasc Dis. 2007;24(1):127-9. Epub 2007 Jun 11. No abstract available.

PMID:
17565198
34.

Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis.

Kuenzle S, von Büdingen HC, Meier M, Harrer MD, Urich E, Becher B, Goebels N.

Infect Immun. 2007 Aug;75(8):3842-7. Epub 2007 May 21.

35.

Ultrasound diagnostics of the vertebrobasilar system.

von Büdingen HC, Staudacher T, von Büdingen HJ.

Front Neurol Neurosci. 2006;21:57-69. doi: 10.1159/000092385. Review.

PMID:
17290126
36.

Early recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysis.

Georgiadis D, Engelter S, Tettenborn B, Hungerbühler H, Luethy R, Müller F, Arnold M, Giambarba C, Baumann CR, von Büdingen HC, Lyrer P, Baumgartner RW.

Circulation. 2006 Jul 18;114(3):237-41. Epub 2006 Jul 10.

PMID:
16831985
37.

Good outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms.

Baumann CR, Baumgartner RW, Gandjour J, von Büdingen HC, Siegel AM, Georgiadis D.

Stroke. 2006 May;37(5):1332-3. Epub 2006 Mar 23.

PMID:
16556881
38.

Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.

Stüve O, Youssef S, Weber MS, Nessler S, von Büdingen HC, Hemmer B, Prod'homme T, Sobel RA, Steinman L, Zamvil SS.

J Clin Invest. 2006 Apr;116(4):1037-44. Epub 2006 Mar 16.

39.

Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.

von Büdingen HC, Menge T, Hauser SL, Genain CP.

Immunogenetics. 2006 Apr;58(2-3):122-8. Epub 2006 Mar 10.

PMID:
16528499
40.

Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.

Lalive PH, Menge T, Delarasse C, Della Gaspera B, Pham-Dinh D, Villoslada P, von Büdingen HC, Genain CP.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2280-5. Epub 2006 Feb 3.

41.

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP.

J Allergy Clin Immunol. 2005 Aug;116(2):453-9.

PMID:
16083805
42.

[Statins for treatment of CNS diseases. Status report from research and clinical practice].

Menge T, von Büdingen HC, Zamvil SS, Hartung HP, Kieseier BC, Stüve O.

Nervenarzt. 2005 Apr;76(4):426-37. Review. German.

PMID:
15448914
43.
44.

Following the tracks of immune responses.

von Büdingen HC, Skulina C.

Trends Biotechnol. 2003 Oct;21(10):415-7. No abstract available.

PMID:
14512223
45.

Approved and future pharmacotherapy for multiple sclerosis.

Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS.

Neurologist. 2002 Sep;8(5):290-301.

PMID:
12803676
46.

Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination.

von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP.

Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8207-12.

47.

Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus.

von Büdingen HC, Hauser SL, Nabavi CB, Genain CP.

Immunogenetics. 2001 Sep;53(7):557-63.

PMID:
11685468
48.

Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

von Büdingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, Genain CP.

J Clin Immunol. 2001 May;21(3):155-70. Review.

PMID:
11403222
49.

[Ondine's curse with convulsive syncope. Clinical and Doppler ultrasound observations].

Dieterle L, Staudacher T, von Büdingen HJ.

Nervenarzt. 1991 Dec;62(12):754-9. German.

PMID:
1795755

Supplemental Content

Loading ...
Support Center